Notice of proposed sale of securities
UNITED STATES     OMB APPROVAL

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 144

 

NOTICE OF PROPOSED SALE OF SECURITIES

PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

 

ATTENTION:       Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker

   

OMB Number:

Estimated average burden

hours per response

 

3235-0101

 

2.00

       
    SEC USE ONLY
   

DOCUMENT SEQUENCE NO.

 

   

CUSIP NUMBER

 

1 (a) NAME OF ISSUER (Please type or print)

 

RTI Biologics, Inc.

 

(b) IRS IDENT. NO.

 

59-3466543

      

(c) S.E.C. FILE NO.                    

 

0-31271

   

WORK LOCATION

 

1 (d) ADDRESS OF ISSUER        STREET                                                         CITY                                     STATE                     ZIP CODE      

(e) TELEPHONE NO.

 

11621 Research Circle PO Box 2650                    Alachua                FL                 32616  

3452)

386

 

NUMBER

418-8888

2 (a) NAME OF PERSON FOR WHOSE ACCOUNT THE SECURITIES

        ARE TO BE SOLD

  

(B)IRS IDENT. NO.

 

 

(c) RELATIONSHIP

      TO ISSUER

  

(d) ADDRESS STREET

  

  CITY

  

STATE

  

ZIP CODE

Adrian J.R. Smith

 

   N/A       Director    11621 Research Circle    Alachua        FL    32616

INSTRUCTION: The person filing this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number.

 

3 (a)

   (b)         SEC USE ONLY    (c)    (d)    (e)    (f)    (g)

Title of the

Class of

Securities

To Be Sold

  

Name and Address of Each Broker Through Whom the

Securities are to be Offered or Each Market Maker

who is Acquiring the Securities

  

 

Broker-Dealer

File Number

  

Number of Shares

or Other Units

To Be Sold

(See Instr. 3(c))

  

Aggregate

Market

Value

(See Instr. 3(d))

  

Number of Shares

or Other Units

Outstanding

(See Instr. 3(e))

  

Approximate

Date of Sale

(See Instr. 3(f))

(MO. DAY YR.)

  

Name of Each

Securities

Exchange

(See Instr. 3(g))

               
COMMON       

E*TRADE FINANCIAL

4005 Windward Plaza Drive

Alpharetta, GA 3005

 

 

 

       

10,000

 

 

 

  

$45,000

 

 

 

  

54,286,673

 

 

 

  

8/3/2009

 

 

 

  

Nasdaq

 

 

 

                        
               
                                    
               
                        
                                    

INSTRUCTIONS:

 

1.

  (a)   Name of issuer
  (b)   Issuer’s I.R.S. Identification Number
  (c)   Issuer’s S.E.C. file number, if any
 

(d)

(e)

 

Issuer’s address, including zip code

Issuer’s telephone number, including area code

2.

  (a)   Name of person for whose account the securities are to be sold
 

(b)

 

  Such person’s I.R.S. identification number, if such person is an entity
  (c)   Such person’s relationship to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of any of the foregoing)
  (d)   Such person’s address, including zip code

 

3.   (a)   Title of the class of securities to be sold
  (b)   Name and address of each broker through whom the securities are intended to be sold
  (c)   Number of shares or other units to be sold (if debt securities, give the aggregate face amount)
  (d)   Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this notice
  (e)  

Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or statement published by the issuer

Approximate date on which the securities are to be sold

  (f)  
  (g)   Name of each securities exchange, if any, on which the securities are intended to be sold


TABLE I - SECURITIES TO BE SOLD

Furnish the following information with respect to the acquisition of the securities to be sold

and with respect to the payment of all or any part of the purchase price or other consideration therefor:

 

Title of

the Class

 

 

 

Date you            

Acquired            

 

  Nature of Acquisition Transaction          

 

Name of Person from Whom Acquired      

(If gift, also give date donor acquired)      

 

 

 

Amount of        
Securities Acquired        

 

 

 

Date of        
Payment        

 

  Nature of Payment
                               
Common    

Stock

  5/8/2009               Exercise of Employee Stock Options       RTI Biologics, Inc.   12,200           5/8/2009         Cash
INSTRUCTIONS:    1.   

If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

      2.   

If within two years after the acquisition of the securities the person for whose account they are to be sold had any short positions, put or other option to dispose of securities referred to in paragraph (d)(3) of Rule 144, furnish full information with respect thereto.

  

 

 

TABLE II - SECURITIES SOLD DURING THE PAST 3 MONTHS

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose  account the securities are to be sold.

Name and Address of Seller   Title of Securities Sold       Date of Sale        

Amount of

Securities Sold

        Gross Proceeds      
                 
                               
                               
                                         

REMARKS:

 

INSTRUCTIONS:   ATTENTION:  

See the definition of “person” in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

 

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed.

 
  July 31,2009                           /s/ Adrian J.R. Smith  
                              DATE OF NOTICE     (SIGNATURE)                                           

The notice shall be signed by the person for whose account the securities are to be sold. At least one copy of the  notice shall be manually signed.

Any copies not manually signed shall bear typed or printed signatures.

 

 

ATTENTION:  Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)